# OnCo record il-yang-pharmaceutical (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/il-yang-pharmaceutical/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "il-yang-pharmaceutical" ;
  schema:name "Il-Yang Pharmaceutical"@en ;
  schema:alternateName "Il-Yang Pharm"@en, "Ilyang"@en, "일양약품"@en ;
  schema:description "Il-Yang Pharmaceutical is a South Korea-based pharmaceutical company that leads 2 cancer trials in OnCo, testing the BCR-ABL inhibitor radotinib (Supect) in chronic myeloid leukaemia."@en ;
  schema:url <https://onco.cc/companies/il-yang-pharmaceutical/>, <https://www.ilyang.co.kr> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://www.ilyang.co.kr>, <https://clinicaltrials.gov/search?lead=Il-Yang%20Pharm.%20Co.%2C%20Ltd.> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "KR" ;
  onco:cancers <https://onco.cc/cancers/cml/> ;
  onco:drugs <https://onco.cc/drugs/imatinib/>, <https://onco.cc/drugs/radotinib/> ;
  onco:trials <https://onco.cc/trials/nct03459534/>, <https://onco.cc/trials/nct03722420/> .